Paul Tudor Jones’s QIAGEN NV QGENF Stock Holding History

Paul Tudor Jones’s Portfolio QGENF Stock Details QGENF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-17,000	Closed	-$466K	–	1809
2016 Q3	$466K	Buy	17,000 +800	+5%	+$21.9K	0.01%	771
2016 Q2	$353K	Buy	+16,200	New	+$353K	0.01%	1062
2015 Q3	–	Sell	-9,500	Closed	-$236K	–	1946
2015 Q2	$236K	Hold	9,500	–	–	0.01%	1257
2015 Q1	$239K	Buy	+9,500	New	+$239K	0.01%	1190

Other funds holding QGENF

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

MNA

Manning & Napier Advisors Fairport, New York $7.8B AUM 25.03% 1-Year Est. Return

HJGA

Hardman Johnston Global Advisors Stamford, Connecticut $2.85B AUM 35.77% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Paul Tudor Jones's QGENF Position: Q4 2016 in Review

Paul Tudor Jones sold out of QIAGEN NV (QGENF) in Q4 2016, closing a stake of 17,000 shares — an estimated $466K sold.

Paul Tudor Jones first reported a position in QGENF in Q1 2015 and held it in 4 quarters. The position peaked at $466K in Q3 2016. 189 funds tracked by Wall St. Rank hold QGENF as of Q4 2016.

Paul Tudor Jones reported no remaining QIAGEN NV position as of Q4 2016 after selling out during the quarter.
Paul Tudor Jones sold 17,000 QIAGEN NV shares in Q4 2016, an estimated $466K.
Paul Tudor Jones first reported a position in QIAGEN NV in Q1 2015 and held it in 4 quarters.
Paul Tudor Jones's QIAGEN NV position peaked at $466K in Q3 2016.
189 funds tracked by Wall St. Rank held QIAGEN NV as of Q4 2016.

Based on Tudor Investment Corp's 13F filing for Q4 2016, filed 14 Feb 2017.